1 / 5

Antibody Drug Conjugates (ADC) Market

Antibody Drug Conjugates (ADC) Market

Aashish10
Télécharger la présentation

Antibody Drug Conjugates (ADC) Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Antibody Drug Conjugates (ADC) Market - Industry Size, Growth, Trends and Forecast to 2031  Global Antibody Drug Conjugates (ADC) Market, By Target (Antibody-Protein Toxin Conjugates, Antibody-Chelated Radionuclide Conjugates, Antibody-Small-Molecule Drug Conjugates, Antibody-Enzyme Conjugates), Product (Adcertis, Kadcyla, Others), Mechanism of Action (CD30 Antibodies, HER2 Antibodies), Technology (Immunogen Technology, Seattle Genetics Technology, Immunomedics Technology, Others), Indication (Lymphoma, Breast Cancer, Brain Tumor, Lung Cancer, Ovarian Cancer, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) - Industry Trends and Forecast to 2030. Browse Full Report :  https://www.databridgemarketresearch.com/reports/global-antibody-drug-conjugates-market

  2. Antibody Drug Conjugates (ADC) Market Report Description Data Bridge Market Research analyses that the Global Antibody Drug Conjugates (ADC) Market which was USD 4750 Million in 2022 is expected to reach USD 26040.61 Million by 2030 and is expected to undergo a CAGR of 23.70% during the forecast period of 2022 to 2030 Get a Sample PDF of Antibody Drug Conjugates (ADC) Market Research @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-antibody-drug-conjugates-market

  3. Antibody Drug Conjugates (ADC) Market player analysis- This Global Antibody Drug Conjugates (ADC) Market report provides the information of the Major Key Players in the market their business strategy, financial situation etc. Seagen Inc. (U.S.), Genentech Inc. (U.S.), Pfizer Inc. (U.S.), Novartis AG (Switzerland), F. Hoffmann-LA Roche Ltd. (Switzerland), Bristol -Myers Squibb (U.S.), Merck & Co., Inc. (U.S.), Immunomedics Inc. (U.S.), Takeda Pharmaceutical Company Limited (Japan), Onconova Therapeutics (U.S.), Helsinn Healthcare SA (Switzerland), Abbott (U.S.), Boehringer Ingelheim International GmbH (Germany), Johnson & Johnson Private Limited (U.S.), DAIICHI SANKYO COMPANY, LIMITED. (Japan), and AbbVie Inc. (U.S.)   Get a TOC PDF of Antibody Drug Conjugates (ADC) Market Research @  https://www.databridgemarketresearch.com/toc/?dbmr=global-antibody-drug-conjugates-market

  4. Regional Analysis

  5. About Data Bridge Market Research An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth  the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Read Continue : http://databridgemarketresearch.com/about-us/ Global Contacts US: +1 614 591 3140 UK: +44 845 154 9652 APAC : +653 1251 975 Email – corporatesales@databridgemarketresearch.com

More Related